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Arsenic (As) is a natural element that is ubiq-
uitous in the environment in both organic 
and inorganic forms. Human exposure to 
inorganic arsenic (iAs), the more toxic form, 
occurs in environmental and occupational 
settings, as well as through medicinal arseni-
cal use (Abernathy et al. 1999; Aposhian 
and Aposhian 2006). The skin is one of the 
most sensitive organs to chronic iAs toxicity. 
Arsenic-induced nonmalignant skin lesions, 
including hyperkeratosis and dyspigmentation, 
are some of the most common and earliest 
signs of chronic iAs exposure (Pi et al. 2000; 
Yoshida et al. 2004). Skin cancers associated 
with human iAs exposure include squamous 
cell carcinoma, basal cell carcinoma, intraepi-
dermal carcinoma, and Bowen’s disease (carci-
noma in situ) (Alain et al. 1993; International 
Agency for Research on Cancer 2004; 
Schwartz 1996; Wong et al. 1998). Although 
As is a well-established human skin toxicant, 
the underlying molecular mechanism(s) is still 
unclear. Accumulating evidence reveals that 
oxidative stress occurs in response to inor-
ganic arsenite (iAs3+) exposure (Pi et al. 2002, 
2003b; Zhao et al. 2011), which may account 
for the dermal toxicity induced by iAs3+, 
including hyperkeratosis and carcinogenesis.
Nuclear factor erythroid-derived factor 
2–related factor 2 (NRF2), which belongs to 
the cap ’n’ collar (CNC) subfamily of basic-
region leucine zipper (bZIP) transcription 
factors, is a central regulator in the cellular 
adaptive antioxidant response to oxidative 
stress (Villeneuve et al. 2010; Zhang 
2010). The CNC subfamily also includes 
NRF1 (NFE2L1/LCRF1/TCF11), NRF3 
(NFE2L3), and the nuclear factor-erythroid 2 
p45 subunit, as well as more distantly related 
factors such as BTB and CNC homology 1 
(BACH1) and BACH2 protein. Under non-
stressed conditions, NRF1 is targeted to the 
endoplasmic reticulum (Biswas and Chan 
2010), whereas NRF2 is primarily in the 
cytoplasm. When cells are under oxidative 
stress, NRF2 and/or NRF1 dimerize with 
small Maf or other bZIP proteins in the 
nucleoplasm, and the heterodimer binds to 
the cis-acting element(s) called antioxidant 
response elements (AREs) in the promoters of 
target genes, leading to their transcriptional 
activation (Biswas and Chan 2010; Maher and 
Yamamoto 2010). Kelch-like ECH-associated 
protein 1 (KEAP1), a cytoplasmic protein, 
serves as a substrate-adaptor molecule for 
cullin-3–based ubiquitin E3 ligase (Kobayashi 
et al. 2004; Zhang 2010). Under non  stressed 
conditions, KEAP1 binds to NRF2 and 
represses the activity of NRF2 by promoting 
its ubiquitination and proteasome-dependent 
degradation (Kobayashi et al. 2004; Villeneuve 
et al. 2010). When cells are exposed to 
electrophiles or oxidants, modification of the 
sulfhydryl groups in KEAP1 occurs, liberating 
NRF2 from KEAP1-mediated degradation, 
and NRF2 accumulates in the nucleus 
(Dinkova-Kostova et al. 2002; Motohashi and 
Yamamoto 2004). Fibroblasts derived from 
Nrf1-mutant mouse embryos and human 
keratinocytes with NRF1 knockdown (KD) 
showed reduced glutathione (GSH) levels 
and higher sensitivity to the toxic effects of 
oxidants, including iAs3+ (Kwong et al. 1999; 
Zhao et al. 2011), suggesting a critical role for 
NRF1 in cellular oxidative defense. Although 
previous studies have suggested that NRF1 
interacts with KEAP1 (Biswas and Chan 2010; 
Zhao et al. 2011), the biological significance of 
this interaction is still poorly characterized. In 
particular, the cross-regulations among NRF2, 
KEAP1, and NRF1 under oxidative stress 
conditions have not been fully investigated.
Previous studies (Aono et al. 2003), 
including our own (Pi et al. 2003b), sug-
gested that NRF2 is a key player in the cellular 
adaptive response to iAs3+-induced oxidative 
stress, whereas constitutive NRF2 activation 
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Ba c k g r o u n d: Nuclear factor E2-related factors (NRFs), including NRF2 and NRF1, play critical 
roles in mediating the cellular adaptive response to oxidative stress. Human exposure to inorganic 
arsenic, a potent oxidative stressor, causes various dermal disorders, including hyperkeratosis and 
skin cancer.
oB j e c t i v e: We investigated the cross-regulations among NRF2, NRF1, and KEAP1, a cullin-3–adapter 
protein that allows NRF2 to be ubiquinated and degraded by the protea  some complex, in arsenic-
induced antioxidant responses.
re s u l t s: In human keratinocyte HaCaT cells, selective knockdown (KD) of NRF2 by lentiviral 
short hairpin RNAs (shRNAs) significantly reduced the expression of many antioxidant enzymes 
and sensitized the cells to acute cytotoxicity of inorganic arsenite (iAs3+). In contrast, silencing 
KEAP1 led to a dramatic resistance to iAs3+-induced apoptosis. Pretreatment of HaCaT cells with 
NRF2 activators, such as tert-butylhydroquinone, protects the cells against acute iAs3+ toxicity in an 
NRF2-dependent fashion. Consistent with the negative regulatory role of KEAP1 in NRF2 activa-
tion, KEAP1-KD cells exhibited enhanced transcriptional activity of NRF2 under non  stressed con-
ditions. However, deficiency in KEAP1 did not facilitate induction of NRF2-target genes by iAs3+. 
In addition, NRF2 silencing reduced the expression of KEAP1 at transcription and protein levels 
but increased the protein expression of NRF1 under the iAs3+-exposed condition. In contrast, silenc-
ing KEAP1 augmented protein accumulation of NRF2 under basal and iAs3+-exposed conditions, 
whereas the iAs3+-induced protein accumulation of NRF1 was attenuated in KEAP1-KD cells.
co n c l u s i o n s: Our studies suggest that NRF2, KEAP1, and NRF1 are coordinately involved in the 
regulation of the cellular adaptive response to iAs3+-induced oxidative stress.
key w o r d s : antioxidant response, arsenic, cytotoxicity, KEAP1, keratinocyte, NRF1, NRF2. 
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may be involved in arsenic carcinogenesis (Pi 
et al. 2008a). Our recent studies also demon-
strated that long isoforms of NRF1 contrib-
ute to iAs3+-induced antioxidant response 
in human keratinocytes and protect the cells 
from acute arsenic cytotoxicity (Zhao et al. 
2011). In the present study, the roles of NRF2 
and KEAP1 in iAs3+-induced cytotoxicity 
and apoptosis, as well as the cross-regulations 
among NRF2, KEAP1, and NRF1 in response 
to acute iAs3+ exposure, were studied by using 
human keratino  cyte HaCaT cells with selective 
knockdown of NRF2 and KEAP1 by lentiviral 
delivery of short hairpin RNAs (shRNAs). We 
demonstrated that cross-talk among NRF2, 
KEAP1, and NRF1 is an important part of 
iAs3+-induced antioxidant response and con-
tributes to the coordinate regulation of anti-
oxidant and detoxifi  cation enzyme expression, 
thus protecting cells from arsenic-induced 
apoptosis and cytotoxicity. Together with our 
previous findings (Zhao et al. 2011), we pro-
pose a comprehensive regulatory mechanism 
for iAs3+-induced adaptive antioxidant response 
in target cells of arsenic exposure, which may 
help advance our understanding of the mecha-
nisms by which arsenic causes skin disorders.
Materials and Methods
Reagents and cell culture. Sodium arsenite 
and tert-butylhydroquinone (tBHQ) were 
obtained from Sigma (St. Louis, MO, USA). 
The HaCaT cell is a spontaneously immortal-
ized human epithelial cell line developed by 
Boukamp et al. (1988). The cells were cul-
tured in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum 
(FBS), 100 U penicillin/mL, and 100 μg strep-
tomycin/mL, as described previously (Pi et al. 
2003b). Cultures were maintained at 37°C in 
a humidified 5% CO2 atmosphere. Culture 
media, FBS, and supplements were purchased 
from Invitrogen (Carlsbad, CA, USA).
Lentiviral-based shRNA transduction. 
MISSION shRNA lentiviral particles were 
obtained from Sigma. Transduction of HaCaT 
cells with lentiviral-based shRNAs target-
ing NRF2 (SHVRS-NM_006164), KEAP1 
(SHVRS-NM_012289), or scrambled non-
target negative control (SHC002V) was per-
formed as described previously (Zhao et al. 
2011). Cells were maintained in medium con-
taining 1.0 μg/mL puromycin.
Quantitative real-time reverse-transcriptase 
polymerase chain (RT-PCR) reaction 
analysis. Total RNA was isolated with TRIzol 
(Invitrogen) and then subjected to cleanup 
by using the RNase-Free DNase Set and the 
RNeasy Mini kit (Qiagen, Valencia, CA, 
USA). Quantitative real-time RT-PCR was 
performed as described previously (Zhao 
et al. 2011). Primers [sequences are shown in 
Supplemental Material, Table 1 (http://dx.doi.
org/10.1289/ehp.1104580)] were designed by 
using Primer Express 4 (Applied Biosystems, 
Carlsbad, CA, USA) and synthesized by MWG 
Biotech Inc. (High Point, NC, USA). Real-
time fluorescence detection was carried out by 
using an Applied Biosystems 7900HT Fast 
Real-Time PCR System (Applied Biosystems).
Western blot analysis. Protein isolation 
from whole-cell lysates and Western blotting 
were performed as detailed previously (Pi et al. 
2003b; Zhao et al. 2011). Antibodies for NRF2 
(sc-13032; 1:500), KEAP1 (sc-15246; 1:500), 
NRF1 (sc-13031; 1:500), and heme oxyge-
nase 1 (HMOX-1; sc-136902; 1:500) were 
purchased from Santa Cruz Biotechnology 
Inc. (Santa Cruz, CA, USA). Antibody for 
NAD(P)H:quinone oxidoreductase 1 (NQO1; 
39-3700; 1:1,000) was purchased from 
Invitrogen. Antibodies for β-ACTIN (A1978; 
1:2,000) and glutamate-cysteine ligase, cata-
lytic subunit (GCLC; RB-1697; 1:800) were 
from Sigma and Lab Vision (Fremont, CA, 
USA), respectively.
Measurement of intracellular GSH. Cells 
were sonicated in cold phosphate-buffered 
saline immediately after collection, followed 
by centrifugation at 12,000 × g for 5 min. The 
resulting supernatants were used for measure-
ment of total GSH by using the BIOXYTECH 
GSH/GSSG-412 kit (OxisResearch, Portland, 
OR, USA) (Fu et al. 2010).
Acute cytotoxicity assay. A minimum of 
five replicates of 10,000 cells per well were 
plated in 96-well plates and allowed to adhere 
to the plate for 24 hr, at which time the 
media were removed and replaced with fresh 
media containing arsenic compounds. Cells 
were then incubated for an additional 24 hr, 
and cell viability was determined by using the 
Non-Radioactive Cell-Proliferation Assay Kit 
(Promega, Madison, WI, USA) as detailed 
previously (Zhao et al. 2011). Measurements 
were expressed as percentage change from 
untreated control (vehicle) of appropriate 
cells. The concentrations that were lethal to 
50% of cells (LC50) were determined from 
analysis of the log-linear phase of the curves.
Determination of apoptosis by flow cytom-
etry. Cells were seeded in six-well plates and 
cultured to approximately 80% confluence. 
Twenty hours after iAs3+ exposure, the cells, 
including floating and attached cells, were 
harvested for apoptosis analysis. Detection of 
phosphatidylserine on the outer leaflet of apop-
totic cells was performed using TACS Annexin 
V-FITC (fluorescein isothiocynate) Apoptosis 
Detection Kit (Trevigen, Gaithersburg, MD, 
USA) as detailed previously (Pi et al. 2005). 
For each sample, 10,000 cells were examined 
by flow cytometry (FACS Vantage; Becton 
Dickinson, San Jose, CA, USA). Percentage of 
apoptotic cells (annexin V positive) was deter-
mined by statistical analysis of the various dot 
plots with the BD FACS Diva, version 6.1.2 
(BD Biosciences, Bedford, MA, USA).
Statistical analyses. All statistical analy-
ses were performed using Graphpad Prism 4 
(GraphPad Software, San Diego, CA, USA), 
with p < 0.05 taken as significant. Data are 
expressed as mean ± SE. Statistical analyses 
to evaluate the effect of shRNAs on the gene 
expression of NRF2 and KEAP1 and intra-
cellular GSH levels were carried out by using 
one-way analysis of variance (ANOVA) with 
Tukey’s or Dunnett’s multiple comparison 
test. Statistical analyses to evaluate the time- 
and concentration-dependent effect of iAs3+ 
exposure on gene expression and cell viability 
were performed by using two-way ANOVA 
with Bonferroni post hoc testing.
Results
Stable knockdown of NRF2 and KEAP1 in 
HaCaT cells. To study the role of NRF2-
mediated antioxidant response in iAs3+-  induced 
cytotoxicity, we performed lentiviral shRNA-
mediated knockdown of NRF2 and KEAP1 
in HaCaT cells. As shown in Figure 1, five 
shRNAs were used to target each of the two 
genes. One construct (sh-NRF2-1) markedly 
silenced NRF2 expression compared with the 
scrambled non  target negative control (SCR), 
whereas the other four NRF2 constructs had 
moderate silencing effects (Figure 1A). The 
effectiveness of knockdown by sh-NRF2-1 
(NRF2-KD) was further confirmed by notably 
diminished protein accumulation of NRF2 
when induced by tBHQ, a potent NRF2 
activator (Pi et al. 2007). Our previous data 
indicated that two phos  phorylated forms of 
human NRF2 near 95–120 kDa accumulate 
in the nucleus after chemically induced oxi-
dative stress, including acute iAs3+ exposure 
(Pi et al. 2007). In the present study, both of 
the NRF2 bands were diminished by lentivi-
ral shRNA-mediated knockdown, confirming 
that the silencing is effective and providing 
additional support for our previous findings (Pi 
et al. 2007). In addition, the protein expression 
of ARE-dependent genes NQO1 and GCLC 
was attenuated, indicating that the transcrip-
tional activity of NRF2 was suppressed in the 
NRF2-KD cells (Figure 1B).
Similarly, HaCaT cells transduced with 
construct sh-KEAP1-1 (KEAP1-KD) showed 
the most efficient knockdown of KEAP1 
expression (Figure 1C,D). Supporting the 
silencing effect of KEAP1, enhanced expres-
sion of NQO1 and GCLC was observed in 
KEAP1-KD cells with or without tBHQ treat-
ment (Figure 1D). Based on the Ensembl 
database, the human KEAP1 has two splice 
variant transcripts coding for the same protein 
of 624 amino acids with a predicted molecu-
lar weight (MW) of 69.7 kDa. However, our 
immunoblots (Figure 1D) using an antibody 
developed against a peptide mapped near the 
N-terminus of human KEAP1 revealed two 
bands with apparent MW between 68 and NRFs and KEAP1 in arsenic-induced antioxidant response
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75 kDa. KEAP1-KD dramatically diminished 
both bands, suggesting that both represent 
endogenous human KEAP1. Clearly, addi-
tional research is required to characterize the 
two isoforms of KEAP1.
The key enzymes that regulate de novo 
GSH synthesis, including GCLC, glutamate-
cysteine ligase, modifier subunit (GCLM), and 
glutathione synthetase, are well-documented 
ARE-dependent genes. Thus, intracellular GSH 
is an important indicator for the transcriptional 
activity of NRF2. As shown in Figure 1E, the 
intracellular GSH level in NRF2-KD cells was 
significantly decreased, whereas KEAP1-KD 
cells exhibited a modest but statistically sig-
nificant increase in the GSH level compared 
with that of SCR cells, confirming the silenc-
ing effect of NRF2 and KEAP1.
Stable knockdown of NRF2 results in 
attenuated antioxidant induction in response 
to iAs3+ exposure. To define the role of NRF2-
mediated antioxidant response in cellu  lar 
defense against iAs3+ toxicity, NRF2-KD 
and SCR cells were acutely exposed to iAs3+, 
and the expression of NRF2 and the ARE-
dependent genes HMOX-1, NQO1, GCLC, 
GCLM, and sulfiredoxin (SRX) was deter-
mined [Figure 2A,B; see also Supplemental 
Material, Figure 1A,B (http://dx.doi.
org/10.1289/ehp.1104580)]. In SCR cells, 
iAs3+ concentration- and time-dependently 
increased NRF2 and ARE-dependent gene 
expression at both mRNA (Figure 2A; see 
also Supplemental Material, Figure 1A) and 
protein (Figure 2B; see also Supplemental 
Material, Figure 1B) levels, confirming our 
previous findings that iAs3+ is a potent NRF2 
activator (Pi et al. 2003b, 2007). In con-
trast, NRF2-KD cells exhibited dramatically 
attenuated expression of NRF2 and ARE-
dependent genes under both basal and iAs3+-
exposed conditions (Figure 2A,B; see also 
Supplemental Material, Figure 1A,B).
Stable knockdown of KEAP1 results in 
enhanced basal expression of ARE-dependent 
genes but weakens iAs3+-induced antioxidant 
response. Consistent with the inhibitory 
role of KEAP1 in regulating NRF2-ARE 
activity, KEAP1-KD cells exhibited enhanced 
expression of the ARE-dependent genes 
HMOX-1, NQO1, SRX1, GCLC, and GCLM 
under basal conditions [Figure 2C,D; see 
also Supplemental Material, Figure 1C,D 
(http://dx.doi.org/10.1289/ehp.1104580)]. 
In apparent contrast to the enhanced basal 
expression, deficiency in KEAP1 diminished 
iAs3+-induced expression of HMOX-1 at 
mRNA and protein levels (Figure 2C,D; see 
also Supplemental Material, Figure 1C,D). 
In addition, no constant increase in iAs3+-
induced expression of other ARE-dependent 
genes was observed in KEAP1-KD cells. These 
findings suggest that constitutive activation 
of NRF2 may weaken the induction of 
ARE-dependent genes, in particular HMOX-1, 
in response to acute iAs3+ exposure. Note that 
acute exposure (6 hr) to high concentrations 
of iAs3+ (20–40 μM) suppressed KEAP1 
expression in SCR cells (Figure 2C,D), which 
might contribute to high-concentration iAs3+-
induced NRF2 activation.
Cross-regulations among NRF2, KEAP1, 
and NRF1 in iAs3+-induced antioxidant 
response in HaCaT cells. Although the man-
ner in which NRF2 is regulated by KEAP1 
has been well documented, the effect of NRF2 
deficiency on expression of KEAP1 is not clear, 
in particular under oxidative stress conditions. 
As shown in Figure 3, lack of NRF2 resulted 
in attenuated gene and protein expression of 
KEAP1 under basal and iAs3+-exposed condi-
tions, suggesting that the expression of KEAP1 
is dependent on NRF2. Although deficiency of 
NRF2 did not increase the mRNA expression 
of NRF1 (Figure 3A,C), NRF2-KD cells exhib-
ited increased protein accumulation of NRF1 
under high concentrations of iAs3+ (2.5–20 μM 
for 6 hr and 10 μM for 6–24 hr), suggesting 
that NRF1 may compensate for the deficiency 
of NRF2 under iAs3+-exposed conditions to 
protect the cells from oxidative damage. In 
addition, an induction in NRF1 protein levels 
was observed in SCR cells but was short-lived 
compared with the sustained response observed 
Figure 1. Stable knockdown of NRF2 and KEAP1 by lentiviral shRNAs in HaCaT cells. (A and C) Silencing 
effect of NRF2 (A) and KEAP1 (C) in HaCaT cells transduced with shRNA lentivirus targeted against 
human NRF2, KEAP1, or scrambled (SCR) non  target negative control (sh-SCR) (n = 3). sh-NRF2-1 through 
sh-NRF2-5 indicate shRNAs targeting NRF2; sh-KEAP1-1 through sh-KEAP1-5, shRNAs targeting KEAP1. (B 
and D) Protein expression of NRF2 (B), KEAP1 (D), and NRF2 target genes NQO1 and GCLC in NRF2-KD and 
KEAP1-KD cells. Cells were treated with 50 μM tBHQ for the indicated time, and whole-cell lysates were 
separated on 4–12% Tris-glycine gels. β-ACTIN was used as loading control. (E) Intracellular GSH content 
in NRF2-KD and KEAP1-KD cells (n = 6). 
*p < 0.05 versus SCR (A, C, E).
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in NRF2-KD cells (Figure 3D). In contrast, 
knockdown of KEAP1 augmented the protein 
accumulation of NRF2 under basal and iAs3+-
exposed conditions (Figure 4). Conversely, 
KEAP1-KD cells exhibited reduced protein 
level, but not mRNA expression, of NRF1 
induced by high concentrations of iAs3+ 
(> 5 μM; Figure 4). The weakened protein 
accumulation of NRF1 in response to high 
concentrations of iAs3+ in KEAP1-KD cells 
could result from enhanced NRF2-mediated 
antioxidant response, leading to augmented 
detoxification capacity and/or lowered intracel-
lular iAs3+ level. The difference between mRNA 
and protein expression of NRF1 suggests that 
protein stabilization is a major mechanism for 
NRF1 activation, which is consistent with a 
recent report (Steffen et al. 2010).
Distinct effect of knockdown of NRF2 
or KEAP1 on iAs3+-induced cytotoxicity and 
apoptosis in HaCaT cells. To investigate the 
roles of NRF2 in iAs3+-induced cytotoxic-
ity, acute (24 hr) effects of iAs3+ exposure 
on cell metabolic integrity were measured 
in NRF2-KD and KEAP1-KD HaCaT 
cells. As shown in Figure 5A, deficiency of 
NRF2 significantly enhanced the cells’ sen-
sitivity to iAs3+ toxicity. The LC50 value was 
16.3 ± 2.5 μM in NRF2-KD cells versus 
36.0 ± 2.1 μM in SCR cells (p < 0.05). In 
contrast, knockdown of KEAP1 led to a dra-
matic resistance to iAs3+ toxicity (Figure 5A). 
The LC50 value in the KEAP1-KD cells was 
80.1 ± 3.1 μM, which was significantly higher 
than that of SCR. We then measured iAs3+-
induced apoptosis and necrosis using flow 
cytometry with annexin V-FITC and pro-
pidium iodide double staining. Consistent 
with the results of cytotoxicity, knockdown of 
NRF2 in HaCaT cells dramatically enhanced 
the sensitivity to iAs3+-induced apoptosis, 
whereas deficiency of KEAP1 led to a signifi-
cant apoptotic resistance (Figure 5B).
To provide further support of our 
hypothe  sis that NRF2 activation contributes to 
iAs3+- induced apoptotic resistance, the effect 
of pretreatment of HaCaT cells with NRF2 
activator tBHQ on iAs3+-induced cytotoxicity 
was examined. As shown in Figure 5C, pre-
treatment of SCR cells with non  cytotoxic level 
of tBHQ (25 μM) for 6 hr modestly but sta-
tistically significantly protected the cells from 
subsequent cytotoxicity induced by high con-
centrations of iAs3+. However, pretreatment of 
NRF2-KD cells with tBHQ showed no protec-
tive effect against iAs3+ toxicity, suggesting that 
the protective effect of tBHQ pretreatment is a 
result of NRF2 activation. In addition, no fur-
ther protective effect was observed by tBHQ 
pretreatment in KEAP1-KD cells, possibly 
because NRF2 is already maximally activated 
in these cells and cannot be increased further 
by tBHQ. In contrast, the protective effect of 
pretreatment with non  cytotoxic dose of iAs3+ 
(2.5 μM) revealed a somewhat different pat-
tern. Although iAs3+ pretreatment can protect 
against cytotoxicity subsequently induced by 
higher doses of iAs3+ in SCR cells, the protec-
tion also exists in NRF2-KD cells, suggesting 
that low-dose iAs3+ might trigger, in addi-
tion to NRF2, other adaptive mechanisms, 
such as activation of NRF1 (Figure 5D). Like 
tBHQ pretreatment, iAs3+ pretreatment did 
not provide further protection of KEAP1-KD 
cells from high-dose iAs3+ toxicity. The find-
ing that NRF2 activators exhibited less sig-
nificant effect than KEAP1 silencing on cell 
survival after arsenic treatment suggests that 
Figure 2. Effect of stable knockdown of NRF2 or KEAP1 in HaCaT cells on the induction of ARE-dependent genes in response to acute iAs3+ exposure. Cells were 
exposed to iAs3+ or vehicle (medium) for 6 hr. (A, B) Concentration response of iAs3+-induced mRNA (A) and protein (B) expression of NRF2 and ARE-dependent 
antioxidant genes in NRF2-KD and SCR cells. (C, D) Concentration response of iAs3+-induced mRNA (C) and protein (D) expression of KEAP1 and ARE-dependent 
antioxidant genes in KEAP1-KD and SCR cells. Integers in parentheses after gene names in A and C are cross-threshold PCR cycle numbers in SCR cells treated 
with vehicle. 
*p < 0.05 versus SCR with the same treatment.
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knockdown of KEAP1 resulted in a higher 
level of antioxidant response than did tBHQ 
or arsenic pretreatment and/or that KEAP1 
silencing also activated an NRF2-independent 
mechanism to contribute to the protection.
Discussion
Supporting the importance of NRF2 in cellu-
lar defense is the finding that Nrf2-knockout 
mice show deficiency in the coordinated anti-
oxidant and phase II gene induction program 
and have a higher susceptibility to both oxi-
dative damage and chemical carcinogenesis 
(Chan et al. 2001; Ramos-Gomez et al. 2001). 
In addition, lack of NRF2 in various mam-
malian cells has been reported to be associ-
ated with heightened sensitivity to various 
oxidative insults, including iAs-induced and 
ultraviolet A–induced apoptosis (Calkins et al. 
2005; Hirota et al. 2005; Lee et al. 2003). 
In the present study, we provide evidence 
that NRF2 regulates many ARE-dependent 
genes and contributes to resistance to iAs3+-
induced cytotoxicity and apoptosis in human 
keratino  cytes. In apparent contrast to exten-
sive data showing that lowered NRF2 activity 
predisposes cells to chemical carcinogenesis, 
Figure 3. Stable knockdown of NRF2 in HaCaT cells reduces expression of KEAP1 but augments iAs3+-induced protein accumulation of long isoforms of NRF1. 
(A, B) Concentration response of mRNA (A) and protein (B) expression of KEAP1 and NRF1 in NRF2-KD and SCR cells exposed to various concentrations of iAs3+ 
or vehicle (medium) for 6 hr. (C, D) Time course of mRNA (C) and protein (D) expression of KEAP1 and NRF1 in NRF2-KD and SCR cells in response to 10 μM iAs3+ 
or vehicle. Integers in parentheses after gene names in A and C are cross-threshold PCR cycle numbers in SCR cells treated with vehicle. 
*p < 0.05 versus SCR with the same treatment.
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Figure 4. Effect of stable knockdown of KEAP1 in HaCaT cells on the expression of NRF1 and NRF2 in response to iAs3+ exposure. (A, B) Concentration response of 
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*p < 0.05 versus SCR with the same treatment.
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emerging evidence reveals the dichotomy that 
constitutive activation of NRF2 may contrib-
ute to malignant phenotypes (Padmanabhan 
et al. 2006). Indeed, increased expression 
and activity of NRF2, resulting from muta-
tions in KEAP1 and/or NRF2, have been 
observed in various tumor cells, including 
skin, breast, prostate, lung, head/neck, and 
endometrium (Kim et al. 2010; Ohta et al. 
2008; Padmanabhan et al. 2006; Shibata et al. 
2008; Singh et al. 2006; Stacy et al. 2006). In 
humans, NRF2 activation due to NRF2 or 
KEAP1 gene mutation plays an important role 
in the development of skin squamous cell car-
cinoma (Kim et al. 2010), which is the most 
common type of skin cancer caused by chronic 
iAs exposure. Most recently, DeNicola et al. 
(2011) reported that oncogene-induced NRF2 
transcription promotes reactive oxygen species 
(ROS) detoxification and tumorigenesis. These 
seemingly contradictory findings suggest that 
NRF2 may play paradoxical roles in different 
stages of tumorigenesis. On the one hand, 
NRF2-dependent antioxidant and detoxifica-
tion enzymes may promote the detoxification 
and elimination of ROS and other carcino-
gens to alleviate their carcinogenic effect. On 
the other hand, NRF2 activation may pro-
vide cell survival advantage by contributing 
to acquired apoptotic resistance, which is an 
important event in the process of arsenic- 
induced malignant transformation in many 
cell types, including human keratinocytes 
(Pi et al. 2005, 2008b; Tokar et al. 2010). 
Therefore, the timing and cellular target of 
intervention targeting NRF2 are critically 
important for chemoprevention of cancers.
Hyperkeratosis is one the most common 
human skin disorders caused by chronic iAs 
exposure (Pi et al. 2000; Wong et al. 1998; 
Yoshida et al. 2004). The underlying mecha-
nism is, however, poorly understood. iAs3+ 
has been identified as a potent activator of 
NRF2-mediated antioxidant response (Pi et al. 
2003a), whereas NRF2 and its target genes 
have been reported as important regulators 
in skin-wound healing (Braun et al. 2002) 
and arsenic-induced skin injury (Pi et al. 
2003b, 2008a). In the present study, we 
confirmed the stimulatory effect of iAs3+ on 
NRF2 activation in human keratinocytes and 
demonstrated that high concentrations of 
iAs3+ inhibit the expression of KEAP1, which 
may contribute to NRF2 activation by iAs3+. 
It has been reported that disruption of Keap1 
in mice leads to hyperkeratosis in esophagus, 
forestomach, and skin, most likely because of 
constitutive activation of NRF2 and aberrant 
expression of some ARE-dependent cyto-
keratins (Wakabayashi et al. 2003). Therefore, 
iAs3+-induced persistent activation of NRF2 
may be associated with the pathogenesis of 
skin hyperkeratosis, although additional 
studies are needed to confirm the linkage.
The distinctive roles of NRF2 and NRF1 
in arsenic-induced keratinocyte toxicity have 
been demonstrated in our previous studies 
(Pi et al. 2003b, 2005, 2007, 2008a; Zhao 
et al. 2011). However, the cross-regulations 
among NRF2, NRF1, and KEAP1 in iAs3+-
induced antioxidant response have not been 
investigated. In the present study, we observed 
higher levels of NRF1 protein accumulation 
in NRF2-KD cells than of SCR in response 
to high concentrations of iAs3+ exposure, sug-
gesting that NRF1 may compensate for defi-
ciency of NRF2 in iAs3+-induced antioxidant 
response. This is consistent with the finding 
by Braun et al. (2002) demonstrating that 
mice lacking NRF2 had no significant wound 
healing phenotype partially because of an up-
regulation of NRF1. In contrast, silencing of 
NRF1 in HaCaT cells does not interfere with 
iAs3+-induced NRF2 protein accumulation, 
revealing that NRF2 cannot compensate for 
deficiency of NRF1 in iAs3+-induced antioxi-
dant response (Zhao et al. 2011). In addition, 
reduced KEAP1 expression was observed in 
NRF1-KD HaCaT cells, suggesting a potential 
regulation of KEAP1 by NRF1 (Zhao et al. 
2011). In the present study, we found that 
lack of NRF2 also led to reduced expression 
of KEAP1. Taken together, the reduction 
in expression of KEAP1 in both NRF1- and 
NRF2-KD cells highly suggests that KEAP1 is 
an ARE-dependent gene. It is unclear whether 
Figure 5. iAs3+-induced cytotoxicity and apoptosis in NRF2-KD and KEAP1-KD HaCaT cells. (A) NRF2-KD cells are sensitive, whereas KEAP1-KD cells are resistant, 
to iAs3+-induced cytotoxicity. (B) Quantification of iAs3+-induced apoptotic (annexin V-positive) cells by flow cytometry. Cells were exposed to various concentra-
tions of iAs3+ for 20 hr (n = 3). (C, D) Effects of pretreatment with non  cytotoxic, low-level NRF2 activators on cytotoxicity induced by subsequent exposure to high 
concentrations of iAs3+ in SCR, NRF2-KD, or KEAP1-KD HaCaT cells. HaCaT cells were pretreated with 25 μM tBHQ (C) or 2.5 μM iAs3+ (D) for 6 hr, followed by 
iAs3+ exposure for 24 hr. (n = 6). 
*p < 0.05 versus SCR treated with the same concentration of iAs3+.
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such regulation, if indeed present, has any 
functional significance.
In contrast to increased expression of 
NRF2 and its target genes under basal con-
ditions, a weakened induction of HMOX-1 
by iAs3+ was observed in KEAP1-KD cells. 
This finding is consistent with our previous 
study showing that persistent activation of 
NRF2 by chronic iAs3+ exposure paradoxi-
cally represses NRF2-mediated antioxidant 
induction in response to additional acute oxi-
dative challenges (Pi et al. 2008a). In addi-
tion, KEAP1-KD cells exhibited reduced 
protein levels of NRF1 induced by high 
concentrations of iAs3+, suggesting a poten-
tial association between NRF1 and KEAP1. 
Our previous study indicated that exogenous 
GSH markedly suppresses hypochlorous 
acid-induced NRF2 activation in mouse mac-
rophages (Pi et al. 2008a), suggesting that 
the enhanced GSH levels in KEAP1-KD 
cells may be a critical factor for the weakened 
NRF2 activation. In addition, elevated levels 
of NRF2 and subsequent induction of phase 
II enzymes in KEAP1-KD cells might reduce 
the intracellular concentration of iAs3+ and 
thus result in decreased activation of NRF2 
and NRF1.
In summary, we provide evidence that 
NRF2, KEAP1, and NRF1 interact with each 
other and coordinate regulation of cellular 
adaptive antioxidant responses to acute iAs3+ 
exposure. Given the potential importance of 
oxidative stress in arsenic-induced dermal tox-
icity and carcinogenicity, as well as the critical 
roles of NRF2 and NRF1 in defending against 
oxidative damage and the pathogenesis of skin 
cancer and hyperkeratosis, our findings provide 
an important insight into the mechanism for 
dermal toxicity induced by arsenic exposure.
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